microRNA-137/DCLK1 axis: A novel mechanism regulating tumorigenicity of colon cancer stem cell

被引：0
|
作者：
Sakaguchi, Masazumi
Hisamori, Shigeo
Oshima, Nobu
Sakai, Yoshiharu
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1898
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1898
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells
    Carli, Annalisa L. E.
    Afshar-Sterle, Shoukat
    Rai, Alin
    Fang, Haoyun
    O'Keefe, Ryan
    Tse, Janson
    Ferguson, Fleur M.
    Gray, Nathanael S.
    Ernst, Matthias
    Greening, David W.
    Buchert, Michael
    PROTEOMICS, 2021, 21 (13-14)
  • [22] Curcumin Induces Autophagic Survival of DCLK1+VE Colon Cancer Stem Cells (CSCs), While Co-Treatment With Curcumin and DCLK1-siRNA Eliminates CSCS: Role of Long and Short Isofoms of DCLK1
    O'Connell, Malaney R.
    Sarkar, Shubhashish
    Kantara, Carla
    Singh, Pomila
    GASTROENTEROLOGY, 2014, 146 (05) : S340 - S340
  • [23] The DCLK1 Tumor Stem Cell Marker Is a Central Regulatory Component of the Epithelial-Mesenchymal Transition Program in Colorectal Cancer
    May, Randal
    Weygant, Nathaniel
    Berry, William L.
    Qu, Dongfeng
    Chandrakesan, Parthasarathy
    Sureban, Sripathi M.
    Houchen, Courtney W.
    GASTROENTEROLOGY, 2015, 148 (04) : S573 - S573
  • [24] Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients
    Mirzaei, Alireza
    Tavoosidana, Gholamreza
    Modarressi, Mohammad Hossein
    Rad, Afshin Abdi
    Fazeli, Mohammad Sadegh
    Shirkoohi, Reza
    Tavakoli-Yaraki, Masoumeh
    Madjd, Zahra
    TUMOR BIOLOGY, 2015, 36 (06) : 4801 - 4810
  • [25] Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase
    Weygant, Nathaniel
    Ge, Yang
    Qu, Dongfeng
    Kaddis, John S.
    Berry, William L.
    May, Randal
    Chandrakesan, Parthasarathy
    Bannerman-Menson, Edwin
    Vega, Kenneth J.
    Tomasek, James J.
    Bronze, Michael S.
    An, Guangyu
    Houchen, Courtney W.
    CANCER RESEARCH, 2016, 76 (14) : 4090 - 4099
  • [26] KDM3A, an Epigenetic Mark and DCLK1, Pancreatic Cancer Stem Cell Marker, Interactions Promotes Stemness and Tumorigenesis
    Ghosh, C.
    Palaniyandi, K.
    Paul, S.
    Dandawate, P.
    Rawal, S.
    Subramaniam, D.
    Padhye, S.
    Gunewardena, S.
    Thomas, S.
    Jensen, R.
    Maliski, S.
    Weir, S.
    Iwakuma, T.
    Anant, S.
    Dhar, A.
    PANCREAS, 2018, 47 (10) : 1388 - 1389
  • [27] Short (S) isoform of cancer-stem-cell marker, DCLK1, is critically required to maintain proliferative/tumorigenic potential of colon cancer cells: identification of associated molecular pathways
    O'Connell, Malaney R.
    Sarkar, Shubhashish
    Singh, Pomila
    CANCER RESEARCH, 2014, 74 (19)
  • [28] Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment
    Cao, Zhiyun
    Weygant, Nathaniel
    Chandrakesan, Parthasarathy
    Houchen, Courtney W.
    Peng, Jun
    Qu, Dongfeng
    CANCERS, 2020, 12 (12) : 1 - 17
  • [29] The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer (vol 9, pg 346, 2014)
    Vedeld, Hege Marie
    Skotheim, Rolf I.
    Lothe, Ragnhild A.
    Lind, Guro E.
    EPIGENETICS, 2016, 11 (08) : 635 - 635
  • [30] First-in-class Doublecortin-like kinase 1 (DCLK1) inhibitor for targeting cancer stem cell in hepatocellular carcinoma.
    Yoon, Daseul
    Jung, Seung Hee
    Jang, Ju Young
    Ahn, Ji-Young
    Jo, Seung Jin
    Ko, Donghyun
    Kim, Dong-kyu
    Yu, Su Jong
    CANCER RESEARCH, 2022, 82 (12)
12345